Erythropoietin Therapy for Subarachnoid Hemorrhage

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
DRUG

erythropoietin beta

30,000 units in 6 mL of 0.9% saline IV for 15 minutes every other day for 3 doses within 72 hours after aneurysmal subarachnoid hemorrhage

Trial Locations (1)

CB2 2QQ

Department of Neurosurgery, Addenbrooke's Hospital, Cambridge

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Roche Foundation of Anemia Research (RoFAR, Switzerland)

UNKNOWN

lead

University of Cambridge

OTHER

NCT00140010 - Erythropoietin Therapy for Subarachnoid Hemorrhage | Biotech Hunter | Biotech Hunter